arrow
A

Anne Vincent-Salomon

Institut Curie
H指数:110
被引数:6.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SPARC is involved in the transition from DCIS to invasive ductal carcinoma via a TGFBR-dependent mechanism in breast cancer

SPARC通过TGFBR依赖性机制参与乳腺癌中从DCIS到浸润性导管癌的转化

2026-11-140
OAAI
Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer

芯片肿瘤作为乳腺癌个性化快速药物测试平台

2026-09-010
OAAI
Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer

谷氨酰胺-tRNA合成酶QARS的核内定位揭示了其在卵巢癌DNA损伤反应中的作用

2026-08-070
OA
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer

E-钙黏蛋白失活塑造了浸润性小叶乳腺癌肿瘤微环境的特异性

2026-05-120
OAAI
A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription

一种反复出现的致病性BRCA2截断变异揭示了BRCA2-PCAF复合物在调节NF-κB驱动的转录中的作用

2025-12-100
OA
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment

无参考RNA分析预测三阴性乳腺癌对新辅助治疗的化疗耐药性

2025-12-010
PRE
The role of body mass index at diagnosis in patients with inflammatory breast cancer

炎性乳腺癌患者诊断时体重指数的作用

2025-10-120
OAAI
Safety and Potential Radiosensitizing Effect of Olaparib in Combination With Breast Radiation Therapy for Patients With Triple-Negative Breast Cancer With Residual Disease: Long-Term Results From the RADIOPARP Phase 1 Trial

奥拉帕利联合乳腺放疗在具有残留病灶的三阴性乳腺癌患者中的安全性及潜在放射增敏作用:RADIOPARP 1期试验的长期结果

2025-05-180
OAAI
CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance

乳腺癌肿瘤和引流淋巴结中CD8+ T细胞:PD-1水平、效应功能及预后相关性

2025-05-120
OAAI
Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria

乳腺恶性叶状肿瘤:修订世界卫生组织“全垒打”诊断标准的必要性

2025-04-010
OAAI
Clinico-pathological Characteristics of Breast Invasive Lobular Carcinoma in non-CDH1 genetic predisposition. Experience from the Institut Curie
2025-03-010
PRE
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
2025-01-240
OAAI
Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp
2024-10-140
OAAI